Dr. Scott Rocklage, Working to Improve Health Care for Millions

Scott M. Rocklage, Ph.D., is a managing partner at 5AM Ventures. He became a partner at Venture in 2003 and advanced to a managing partner in 2004. Venture 5AM is a company that provides support through venture capital to companies that are currently working to create solutions to healthcare needs through the development of medications and cutting-edge scientific inventions.

Based in Boston, Massachusetts, Dr. Scott Rocklage is an inventor or co-inventor of over 30 U.S. patents. He was written and published more than 100 peer-reviewed publications.

Over the past 30 years, Dr. Rocklage has acquired management experience in healthcare with tactical leadership responsibilities that have led to the approval by the Federal Drug Administration (FDA) of three U.S. New Drug Applications. Those drugs include Omniscan™, a radiocontrast agent that allows doctors to see the brain, spine, chest, stomach, hip, and other areas in MRI scans, Teslascan®, a contrast agent that assists doctors in looking at the liver, and Cubicin®, an antibiotic used to treat serious skin infections in adults and learn more about Scott.

Dr. Rocklage received his B.S. in Chemistry from the University of California in Berkeley and his earned his Ph.D. in chemistry from the Massachusetts Institute of Technology (MIT) where he also conducted research in the laboratory of Richard R. Schrock, who won the Nobel Prize in Chemistry in 2005.

Along with his tenure at 5AM Ventures, Dr. Rocklage currently serves as the chairman and Chief Executive Officer (CEO) of Cubist Pharmaceuticals, President and CEO of Nycomed Salutar and more information click here.

In keeping in line with the busy doctor he is, Dr. Rocklage has served as the chairman of the boards of Novira and Relypsa and currently serves as the chairman of the board at Rennovia, Kinestral and Cidara as well as on the boards of Epirus and Pulmatrix.

Dr. Rocklage also writes about various topics in his blog at https://scottrocklage.wordpress.com.

Avi Weisfogel among First to Recognize Seriousness of Sleep Apnea

As a single disease entity, sleep apnea has been long ignored by the medical establishment. This has percolated into the consciousness of the American public, with most people viewing sleep apnea as being little more than a bothersome nuisance. Nothing could be further from the truth.

The reality is that sleep apnea is a highly deadly disease, strongly associated with almost every major ailment that produces high numbers of mortalities in the United States every year. Just some of the disease states that sleep apnea is closely associated with include heart attack, stroke, diabetes and lung dysfunction. The disease itself can lead directly to cerebral hypoxia, cardiac hypoxia and fatal arrhythmias. It is estimated to the disease may be partially responsible for tens of thousands of deaths in the United States each year and learn more about Avi.

Avi Weisfogel is one of Central New Jersey’s most prominent dentists. After graduating with a M.D. in dentistry from the New York University School of Dentistry, he founded Old Bridge Dental and quickly grew into one of Central New Jersey’s most respected dental practices. But Dr. Avi Weisfogel always had a nagging sense that dentists were not doing enough to improve the public health. He knew that many dentists are the only medical professional that a large subset of patients will see over the course of a year or even longer. The nature of dental ailments is such that, even the most highly pain-tolerant patients cannot put off such conditions as abscessed molars or severe cavities. Dental infections are among the most painful conditions that there are, often being completely intractable with the use of standard analgesics.

Dr. Weisfogel was well aware of these dynamics. He thought that he could train dentists to recognize and treat sleep apnea, a disorder that goes undiagnosed in over 90 percent of patients that have it and that has some of the worst outcomes of any medical condition and more information click here.

In 2010, Dr. Weisfogel founded Dental Sleep Masters, a program of seminars and educational services dedicated to teaching dentists how to identify and treat sleep apnea. It has been a runaway success, training thousands of dentists in the modern treatment modalities and best practices of sleep apnea treatment.

More visit: http://aviweisfogel.tumblr.com/